These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 33679786)
1. Cascalho M; Platt JL Front Immunol; 2021; 12():634544. PubMed ID: 33679786 [TBL] [Abstract][Full Text] [Related]
2. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089 [TBL] [Abstract][Full Text] [Related]
3. TACI is mutant in common variable immunodeficiency and IgA deficiency. Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086 [TBL] [Abstract][Full Text] [Related]
4. TACI mutation in common variable immunodeficiency and IgA deficiency. Rachid R; Castigli E; Geha RS; Bonilla FA Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196 [TBL] [Abstract][Full Text] [Related]
5. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Lee JJ; Ozcan E; Rauter I; Geha RS Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency. Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508 [TBL] [Abstract][Full Text] [Related]
7. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency. Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762 [TBL] [Abstract][Full Text] [Related]
8. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies. Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394 [TBL] [Abstract][Full Text] [Related]
9. TACI mutations and disease susceptibility in patients with common variable immunodeficiency. Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517 [TBL] [Abstract][Full Text] [Related]
10. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846 [TBL] [Abstract][Full Text] [Related]
11. Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations. Freiberger T; Ravčuková B; Grodecká L; Pikulová Z; Stikarovská D; Pešák S; Kuklínek P; Jarkovský J; Salzer U; Litzman J Hum Immunol; 2012 Nov; 73(11):1147-54. PubMed ID: 22884984 [TBL] [Abstract][Full Text] [Related]
13. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655 [TBL] [Abstract][Full Text] [Related]
14. TACI deficiency - a complex system out of balance. Salzer U; Grimbacher B Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095 [TBL] [Abstract][Full Text] [Related]
15. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042 [TBL] [Abstract][Full Text] [Related]
16. Innate Mechanisms in Selective IgA Deficiency. Zhang J; van Oostrom D; Li J; Savelkoul HFJ Front Immunol; 2021; 12():649112. PubMed ID: 33981304 [TBL] [Abstract][Full Text] [Related]
17. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420 [TBL] [Abstract][Full Text] [Related]
18. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194 [TBL] [Abstract][Full Text] [Related]
19. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family. Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058 [TBL] [Abstract][Full Text] [Related]
20. An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene. Sazzini M; Zuntini R; Farjadian S; Quinti I; Ricci G; Romeo G; Ferrari S; Calafell F; Luiselli D Genes Immun; 2009 Sep; 10(6):566-78. PubMed ID: 19494827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]